TardiMed Sciences LLC is 10% Owner at Timber Pharmaceuticals, Inc. (TMBR). They have made 10 open-market trades across 2 companies since 2020, most recently 2021-09-02.
CIK 0001800690
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 80% | 70% |
| Avg Move | -0.9% | -6.8% | -21.5% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TMBR | SELL | 2021-09-02 | 2021-09-02 | $0.94 | $212K | -14.0% | -15.2% | -60.2% |
| TMBR | SELL | 2021-08-30 | 2021-09-01 | $0.92 | $368K | -3.0% | -3.5% | -50.0% |
| TMBR | SELL | 2021-08-24 | 2021-08-26 | $0.92 | $276K | +1.5% | -0.9% | -48.2% |
| TMBR | SELL | 2021-08-18 | 2021-08-20 | $0.96 | $168K | +0.9% | -3.0% | -40.7% |
| TMBR | SELL | 2021-06-14 | 2021-06-15 | $1.27 | $408K | +5.0% | -11.6% | -24.3% |
| TMBR | SELL | 2021-06-08 | 2021-06-10 | $1.28 | $1.5M | -5.6% | -11.1% | -25.4% |
| TMBR | SELL | 2021-05-28 | 2021-06-02 | $1.27 | $145K | +3.2% | -8.8% | -26.2% |
| TMBR | SELL | 2020-09-14 | 2020-09-16 | $1.03 | $387K | -5.3% | +6.1% | +5.1% |
| TMBR | SELL | 2020-09-10 | 2020-09-14 | $1.04 | $42K | -6.1% | +2.9% | +17.5% |
| BPMX | SELL | 2020-02-10 | 2020-02-12 | $0.01 | $550 | +14.1% | -23.3% | +37.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.